Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases.

Abstract

Levels of cProteasomes are markedly elevated in patients with systemic autoimmune diseases, apparently correlating with disease activity. The cProteasomes represent novel sensitive markers of the autoimmune inflammatory processes and/or reflect the magnitude of cellular damage.